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Abstract
Breast cancer is the leading cause of death of women in the United States. Patients at high risk
for developing cancer are more easily identified in today’s world. Early identification might be
due to strong family history or genetic mutations, such as BRCA1 or BRCA2. Screening and risk
reduction guidelines have been developed over recent years for these patients. Adherence to
these guidelines continues to be a problem. The factors stemming from this problem include lack
of knowledge about being high-risk, understanding the guidelines, and anxiety and depression
about the perceived risk of developing breast cancer. These factors can cause a barrier and
prevent patients from following through with their recommended screening or risk reduction
strategy. The purpose of this Doctor of Nursing Practice (DNP) project was to determine if
cancer risk education increases knowledge and self-efficacy and decreases anxiety and
depression. Based on a literature review, the project was developed to evaluate the outcome
variables of self-efficacy, knowledge, anxiety, and depression before and after a standardized
educational intervention for high-risk cancer patients. Data collected were analyzed with a paired
t-test and an increase in knowledge scores from the and post-survey answers were identified as
being statistically significant (p = 0.04). Although anxiety shows a clinical significance, there
were no statistically significant changes in anxiety and depression.

Keywords: high-risk breast cancer, BRCA1 and or BRCA2, risk reduction strategies, breast
cancer screening, screening and risk reduction strategies adherence, anxiety, depression,
education, knowledge, self-efficacy
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Chapter I
Introduction and Background
Breast cancer is one of the leading causes of death in women in the United States.
Approximately one in eight (13%) will be diagnosed with invasive breast cancer in their lifetime,
and one in 39 women (35%) will die from breast cancer (American Cancer Society, 2019). There
are many factors in oncology that can determine if a patient is considered high-risk. The two
most common areas considered are 1) does the patient have a family history of breast cancer and
2) what is the patient’s genetic testing regarding breast cancer.
Knowing a patient’s family history can play an essential role in helping a provider
determine if the patient has an additional risk that might increase their chances of developing
breast cancer. Studies have shown that women with a family history of breast cancer in a firstdegree relative (parent, child, or sibling) are 1.5 times more likely to be diagnosed at a young
age. This group is also more likely to be diagnosed with a more advanced stage of cancer
(American Cancer Society, 2019). Being familiar with a patient’s family history can assist
providers on who needs to undergo further genetic testing.
Genetic testing has become a mainstay when looking at high-risk patients and their
family history. Patients tested and found to be BRCA1 and BRCA2 mutation positive have a
greater than 20% lifetime risk for developing breast cancer (Rosenthal et al., 2017). Expanded
genetic panels have become more readily available to evaluate women who may not have a
strong family history of breast cancer. Expanding beyond the BRCA1/2 mutation significantly
increases the number of women identified as having an increased risk. These women are also
candidates for increased risk reduction measures such as screening by not just mammograms and
breast MRIs (Rosenthal et al., 2017). These patients may also benefit from starting annual
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screening earlier than the United States Preventative Services Task Force recommends. Other
risk reduction recommendations may include prophylactic mastectomies and hysterectomies if
they are also considered high risk for ovarian cancer.
The cost of treating breast cancer also plays a critical role in encouraging adherence to
screening. Blumen et al. (2010) performed a retrospective claims analysis on newly diagnosed
breast cancer patients. They found that the cost of treatment for one year for a Stage 1 cancer
averages about $60,637, whereas the yearly cost for a Stage IV cancer averages about
$134,682.00 (Blumen et al., 2016). This cost included all methods of treatment such as IV and
oral therapy.
Problem and Significance
Adherence to recommended screenings is crucial when patients have a known high risk
or a genetic predisposition. A study performed by the National Cancer Institute suggested that
most women at high risk for breast cancer do not adhere to the recommended mammography
screening guidelines. Only 63% of women aged 50 and older receive their annual screening
mammograms, and 13% of those have never been screened despite their high-risk status
(Watson-Johnson et al., 2011). Patients with genetic mutations are also provided options termed
risk reduction strategies. Recommendations usually include prophylactic mastectomies and
increased surveillance.
Many factors influence adherence to getting a mammogram done on a routine basis.
These factors can range from the mammogram experience itself (Tang et al., 2008) to its cost.
Factors also include lack of knowledge about the need for screening and anxiety about having
the recommended screening performed. The anxiety can be further defined based on the patient’s
perception of the risk of developing breast cancer. According to Katapodi et al. (2004), "studies
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exploring perceived breast cancer risk suggest that lay women hold a different set of beliefs
about breast cancer's causes, curability, and risk factors than health care experts."
Furthermore, since screening is an integral part of managing high-risk patients, the
practitioner needs to know the exact barriers or barriers. Within the practice, advanced practice
registered nurses have many roles. Two of the most critical roles are educator and facilitator
(Vogel, 2003). By educating and facilitating, the advanced practice registered nurse can provide
patients an increased awareness of their risk for developing breast cancer, provide education on
reducing that risk, and facilitate compliance to the recommended screenings.
In addition, this author believes that patients would be more adherent to screening
recommendations by patients knowing and understanding what it means to be at high risk for
breast cancer either due to family history or a genetic mutation. Furthermore, if patients receive
education about their risks and the rationale behind the screening recommendations, it may
improve their adherence to recommendations. Also, patients' education about their risk could
reduce their anxiety about the screening and results. Based on the National Comprehensive
Cancer Network's guidelines, these screening recommendations include mammograms, selfbreast exams, clinical breast exams, and surgical risk reduction strategies.
Primary care providers are usually the ones tasked with ordering mammograms, and they
may not be up to date on the additional screenings required for high-risk patients. Advanced
practice registered nurses can connect with patients making it easier to discuss concerns and
fears about all health issues. Connecting more with the patients may help the patient understand
the importance of screening and risk reduction strategies. The time spent talking with the patients
could reduce breast cancer development by educating patients thoroughly about their risk.
Purpose Statement
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The purpose of this Doctor of Nursing Practice (DNP) project is to determine if cancer
risk education increases knowledge and self-efficacy and decreases anxiety and depression.
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Chapter II
Literature Review
For this chapter, an extensive literature review was performed by this author in the
Cumulative Index of Nursing and Allied Health Literature (CINAHL), Cochrane, PUBMED, and
Scopus databases. Each database search used the same keywords either by themselves or in
combination. The keywords used were “high-risk breast cancer,” “anxiety,” “education,”
“BRCA1,” “BRCA2,” “risk reduction strategies,” “breast cancer screening,” “screening
adherence,” and “risk reduction strategies adherence.” The following synonyms were also used
to enhance the search: neoplasm, carcinoma, anxiety disorders, generalized anxiety, depression,
knowledge, understanding, awareness, prevention strategies, clinical breast exam, self-breast
exam, mastectomy, and mammogram. The keywords and synonyms were combined to narrow
the search, and the results are available in appendix A.
Furthermore, while conducting this review, this author performed three separate searches.
The first was aimed at looking at both adherence behaviors and barriers. The second search
combined the keywords to look at patient anxiety, depression, knowledge level, and perceived
risk for high-risk breast cancer (see Appendix A). Furthermore, although the search parameters
were set to exclude grey papers they did include quality improvement plans. The third search
used the keyword self-efficacy and the ones utilized for the first two searches. After the searches,
it has become clear that the literature is abundant regarding screening adherence based on the
knowledge level and risk perception for patients predisposed to developing breast cancer.
Similarities and Dissimilarities
The literature was reviewed more closely for similarities and dissimilarities across
multiple articles focusing on the first two searches. These articles focused on finding reasons for
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determining why women did or did not adhere to screening recommendations and if knowledge
about risk and anxiety related to risk perception played a part. Based on these articles, data was
collected in three different ways. The studies by Antill et al. (2006), Bredart et al. (2011),
Buchanan et al. (2017), Cabrera et al. (2010), Grimm et al. (2019), Lobb et al. (2006), Phillips et
al. (2006), Price et al. (2010), Roussi et al. (2010), and Tinley et al. (2004) sent their participants
self-reporting questionnaires or handed them out in the clinical setting. Telephone interviews
were used to collect data by Hass et al. (2005), Issacs et al. (2002), Peshkin et al. (2002), Roussi
et al. (2010), and Tang et al. (2009). Katapodi et al. (2003) conducted a meta-analytic review and
evaluated data from 42 articles. Genetic testing results from 9641 participants were also studied.
Furthermore, Drukteinis et al. (2013) looked at options beyond mammography for patients with
dense breast tissue, which can cause abnormalities to be missed by the radiologist. In addition,
two articles were expert opinion papers. The first focused on the oncology nurse’s role in
educating patients about their risk and need for recommended screening. In contrast, the second
article by Sciaraffa et al. (2020) focused on the components needed to develop a successful risk
assessment management program. These articles focused on determining why women did or did
not adhere to screening recommendations.
Similarities
Some similarities across all articles included the questions asked of the participants. In
thirteen articles, participants were asked to provide demographic statistics such as age,
employment status, family income, education level, marital status, ethnicity, number of
offspring, insurance status, mutation status, and family history. Perception of risk for developing
breast cancer was also a data point collected in eighteen of the articles. Psychological factors and
a recollection of what screening measures were recommended to the participants were also data
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points reviewed in the literature. Knowledge, both general and specific to a mutation, was
evaluated in fifteen articles.
Dissimilarities
Dissimilarities between the articles were primarily seen with the type of participant being
evaluated. The articles by Antill et al. (2006), Bredart et al. (2011), Cabrera et al. (2010), Haas et
al. (2005), Lobb et al. (2006), Roussi et al. (2010), and Price et al., (2010) looked only at women
with no personal history of cancer. Still, they had a moderate to high risk based on their genetic
pedigree. Buchanan et al. (2017), Isaacs et al. (2002), Peshkin et al. (2002), Philips et al. (2006),
and Tinley et al. (2004) all looked at participants that were unaffected carriers of the BRCA1 or
BRCA2 gene. Green et al. (2004) included participants with a personal or family history of breast
cancer. Grimm et al. (2019) looked specifically at a women’s subjective estimate of breast cancer
risk and frequency of breast cancer thoughts. The participants for Katapodi et al. (2003) and
Rosenthal et al. (2016) were obtained either from previous research done in a literature review or
a review of genetic testing by a specific laboratory.
There were also some dissimilarities in the screening practices that were evaluated. Seven
out of the ten articles did include mammograms as the primary data point to determine
adherence. Antill et al. (2006), Phillips et al. (2006), Price et al. (2010), and Tinley et al. (2004)
also included breast self-exam (BSE) as a screening measure. Antill et al. (2006), Isaacs et al.
(2002), Peshkin et al. (2002), Phillips et al. (2006), Price et al. (2010), and Tinley et al. (2004) all
included the clinical breast exam (CBE) as a screening measure. Antill et al. (2006), Buchanan et
al. (2017), and Price et al. (2010) looked at patterns of over-screening vs. under-screening in this
high-risk population.
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Phillips et al. (2006) mentioned the risk reduction measure of chemoprevention with
Nolvadex (tamoxifen). This article is the only sample that included genetic counseling as a factor
in evaluating screening adherence. Tinley et al. (2004) was the only article that looked at
compliance based on a specific provider's intervention and recommendation, precisely the
primary care provider.
The mammogram experience itself as a factor in adherence to screening for all
populations was also considered by Tang et al. (2009). This article was included as it helps this
author look at factors outside of the high risk for breast cancer as a reason for not getting
screenings done. Rosenthal et al. (2016) was chosen to help define the most common genetic
mutations for developing breast cancer beyond BRCA1 and BRCA2 now that expanded genetic
panels are available to almost everyone. The meta-analysis done by Katapodi et al. (2003) was
chosen as it looked at multiple sources of data that can help answer the question of screening
adherence. The other articles were selected as they studied different sets of high-risk participants
and looked at all the current significant screening recommendations individually.
Data Concerns
There were some concerns with some of the data reviewed. It was noted that four of the
articles all originated from a single study done in Australia. Participants were pulled from the
Kathleen Cunningham Consortium for Research into Familial Cancer (kConFab) data. Even
though the articles by Antill et al. (2006), Isaacs et al. (2002), Phillips et al. (2006), and Peshkin
et al. (2002) were pulled from the same data pool, their parameters and findings varied across all
the studies. This author is unsure of how much overlap there was in the participants across all
four articles. The same can be said for the articles by Lobb et al., 2005 and 2006. The same
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population pool was used in these articles, as were the same genetic counselors to provide the
education.
Cancer Risk Education and Knowledge
Most had similar results in the 15 articles that studied knowledge and cancer risk
education. By educating the participants about their high-risk status and the implications, their
knowledge level increased, leading to increased adherence to screening recommendations. There
were some differences between how the education was provided. Cabrera et al. (2010), Green et
al. (2004), Lobb et al. (2006), Price et al. (2007), Roussi et al. (2010), and Stalmeier et al. (2009)
used genetic counseling for their educational intervention. In contrast, in 2005 and 2006, Lobb et
al. looked at using a standardized communication tool during counseling sessions. Various tools
were used across all of the studies to evaluate knowledge. The most utilized tools to assess
knowledge were the Cassileth Information Styles Questionnaire and the Breast Cancer Genetics
Knowledge questionnaire. Green et al. (2004) was the only study that used a computer-based
educational tool and compared it to one-on-one genetic counseling. This study revealed that
participants felt their knowledge improved significantly after viewing the tool.
Self-Efficacy
The literature review also revealed that self-efficacy improved as knowledge was gained
and anxiety lessened in most participants. Of the 18 studies that included self-efficacy, only the
study done by Antill et al. (2006) showed no clinical significance in improving participant selfefficacy when education was provided regarding high-risk status. Cabrera et al. (2010) showed
that their intervention with genetic counseling improved self-efficacy to the point that
participants felt comfortable enough to pass the knowledge on to other family members to help
them make more informed choices about undergoing screening. Green et al. (2004) found that
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seeing a genetic counselor was most effective for improving self-efficacy, while Lobb et al.
(2005) felt that genetic counseling sessions should be standardized for better self-efficacy.
Overall improved self-efficacy was also shown to improve adherence to screening
recommendations from the educational tool and genetic counseling session. Patients who were
over-or under-screened stated that they would follow the recommended guidelines, and those
who were not screened also made the same statements. The tools utilized to evaluate selfefficacy included the Life Event and Difficulty Scale, Cognitive-Social Health Information
Processing Model (C-SHIP), Miller Behavioral Style Scale, and the Decision Evaluation Scale.
Anxiety
Anxiety was found to be a significant factor for non-adherence to screening
recommendations. In the 18 articles that studied anxiety, the participants' education significantly
impacted reducing anxiety about being high-risk. Bredart et al. (2011) revealed that anxiety was
higher in the older population, whereas Price et al. (2007) found that anxiety about high-risk was
present in all age groups. This study also found that women unaffected by a relative having
breast cancer had low anxiety levels (Price et al., 2007). Anxiety for women with a genetic
mutation was higher in all the reviewed articles. The more frequently utilized tools for assessing
anxiety were the Spielberg State Anxiety Index (STAI), Impact of Events Scale (IES), and
Hospital Anxiety and Depression Scale (HADS).
Depression
Depression should also be considered as another significant factor for non-adherence.
Most articles focused on depression following a cancer diagnosis in the literature review, not just
being at high risk. Listol et al. (2017) did focus on anxiety and depression symptoms in
hereditary breast and ovarian cancer patients. This study evaluated using group-based patient
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education courses to see if anxiety or depression symptoms changed from before the course to
after (Listol, 2017). This study showed that women with a BRCA mutation felt alone with their
concerns about being a mutation carrier. They wanted to discuss their challenges with peers and
health professionals (Listol, 2017). In the four articles that studied depression in patients
diagnosed with cancer, three were completed while patients actively underwent treatment. One
evaluated depression symptoms following treatment up to five years. Nakamura et al. (2020)
performed serial assessments of depression on both patients and providers for early-stage breast
cancer.
In contrast, Weihs et al. (2018) used the National Institutes of Health (NIH) Stage model
to design and test a single intervention to prevent depression in breast cancer patients at any
stage in their diagnosis. Two international studies were also reviewed. The study by Kim et al.
(2017) evaluated a nurse-led psychological program. It evaluated its effects on psychological
distress and quality of life in patients with breast cancer undergoing chemotherapy and at high
risk for depression in South Korea. In contrast, the study was done on the same group in Mexico
by Doubova et al. (2020). It focused on the association of supportive care needs and quality
patient-centered care for women with depression.
Furthermore, this study's findings revealed that up to 43.6% of women with breast cancer
in Mexico reported substantial unmet supportive care needs and depression symptoms (Doubova
et al., 2020). The studies revealed that depression is common at any stage in breast cancer,
whether it is someone with a high-risk or undergoing treatment. Each of the studies showed
improvement in depression following the study interventions.
Social Learning Theory
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An additional search was conducted to look for evidence to support the project's focus
that increasing knowledge will decrease anxiety and improve self-efficacy. After the initial
search revealed many theories based on the keywords, the search was narrowed to Bandura's
Social Learning Theory. This theory looks at improving self-efficacy with improving knowledge.
An article by Bandura, 1983, described how giving someone money can help overcome a fear of
snakes. The learning theory was further broken down in articles by Cherry (2019), Elder et al.
(1999), Horsburgh et al. (2018), Loveless (2021), and Rosenstock et al. (1988). These articles all
discussed how increasing knowledge would decrease anxiety about perceived risk and improve
self-efficacy, leading to better adherence to recommendations. Schwarzer et al. (1995) even
developed a validated General Self-Efficacy Scale to evaluate someone's ability to respond to
and control environmental demands and challenges.
Summary
After reviewing all the evidence found in the referenced articles for the first two searches,
there does seem to be a direct correlation between knowledge about a patient's high-risk status
and their anxiety about their perception of their risk. These feelings can also lead to either poor
adherence to screening as recommended or not screening due to anxiety and depression. By
developing a program for these patients that focuses on their anxiety, depression, and knowledge
deficits, we may achieve better screening adherence, potentially leading to earlier detection of
breast cancer in this population.
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Chapter III
Conceptual Framework
Albert Bandura's Social Learning Theory will guide this DNP project (Bandura, 1977).
According to Elder et al. (1999), this theory emphasizes the interactions between a person’s
cognition and behavior. Bandura accomplishes this through self-efficacy and outcome
expectancies (or response efficacy). Bandura states that “if people believe they can exercise
control over the occurrence of events that can be injurious, they do not fear them” (Bandura,
1983). Bandura's theory moves beyond traditional behavioral theories, suggesting that all
behaviors are learned through conditioning and cognitive theories and considers psychological
influences such as attention and memory (Cherry, 2019).
Within the theory, there are five major guiding principles for learning. The first principle
states that learning is not just a behavioral process responding to stimuli. Instead, the behavior is
a cognitive process within the larger social environment (Loveless, 2021). The second principle
of this theory is that learning behaviors need to be reinforced either by direct or vicarious
reinforcement. Direct reinforcement uses punishments and rewards to increase or decrease the
likeliness that a behavior will be repeated (Loveless, 2021). Vicarious reinforcement posits that
instead of directly experiencing the consequence, the learner will learn by observing the outcome
of others' actions (Loveless, 2021). The third principle is the importance of observation. While
watching, learners observe an action’s outcomes, including whether it is rewarded or punished
(Loveless, 2021). Reinforcement does support learning with the fourth principle in this theory.
The fourth principle indicates that learning results from multiple influences instead of any
specific ones (Loveless, 2021). The final principle is that learners are active in their learning
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process. They think about their behaviors, engage in their environment, and reciprocate with the
influences that impact them (Loveless, 2021).
Because learning is a very complex process, Bandura's theory was utilized to support this
project. Much of this project focused on reducing the anxiety about being a high-risk breast
cancer patient. By providing education to improve knowledge and self-efficacy, the hope was
that the patients whose perceived effects of changing lifestyles (incentives) will attempt to
change if they believe that (a) their current lifestyles pose threats to any personally valued
outcomes, such as health or appearance (environmental cues); (b) that certain behavioral changes
will reduce the threats (outcome expectations); and (c) that they are personally capable of
adopting the new behaviors (efficacy expectations) (Rosenstock et al., 1988).
Bandura's framework was applied to this project by evaluating a patient's knowledge and
anxiety about being at increased for breast cancer before they undergo standardized education to
improve their self-efficacy. The following steps were used in the educational tool using
Bandura's theory. The first was to make sure the tool was attractive to the learner to hold their
attention. To learn, one must pay attention, as any distraction will have a negative effect on
observational learning (Cherry, 2019). Retention was the next step in learning. If patients cannot
store the information provided, they may not be able to act on the recommendations made in an
educational tool for their specific needs. The third step was reproduction. Once the patient has
given their full attention to the educational tool and has retained the information, it is time for
them to perform the behavior observed (Cherry, 2019). The participants would complete a postsurvey to test how their knowledge and anxiety have changed following the educational
intervention. For the last step, participants showed they are motivated to follow through with the
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recommended screenings to help reduce their risk of developing high-risk breast cancer. This
motivation will be evaluated on the post-survey questionnaire.
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Chapter IV
DNP Final Project
This chapter describes the DNP final project. The project aimed to determine if cancer
risk education increased knowledge and self-efficacy and decreased anxiety and depression. The
chapter addresses the project’s setting, the sample, project tasks, team members, outcomes and
instrumentation, and the project timeline. The discussion includes the project sponsor, key
stakeholders, the organizational assessment, resources and supports, risks and threats, and the
project's financial plan.
Design and Setting
A pre-post evaluative design was utilized for this project. An educational intervention
was provided between the assessments of the project's variables, including knowledge, selfefficacy, anxiety, and depression. The setting for this project was at a large cancer center in
Southern Nevada. This DNP student is a provider for the general oncology division and works
closely with the genetic counselor onsite.
Population and Sample
The population of interest were females at risk for breast cancer related to genetic factors.
The sample included women referred to the genetic counselor for consultation due to potentially
being at high risk for breast cancer, either due to a strong family history of breast cancer or a
genetic mutation for breast cancer. A power analysis estimated that there should be at least 103
participants for this project, so the overall goal was to enroll 120 participants.
Inclusion criteria included females over 18 years of age, having either a family history of
breast cancer or genetic mutation, having a genetic mutation (such as BRCA1/2), and ability to
read and write in English.
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Project Tasks
The project tasks included:
•

Proposal Defense

•

UNLV and project sites IRB approvals

•

Development of educational intervention and assessments

•

Pre-assessment of knowledge, self-efficacy, anxiety, and depression

•

Implementation of an educational session with participants

•

Post-assessment of knowledge, self-efficacy, anxiety, and depression

•

Data analysis and program evaluation

•

Prepare final documents detailing results, conclusions, and discussion

Team
The team for this project comprised the DNP student, the University’s graduate advisory
committee chair and members, the genetic counselor, and the Practice Manager at the cancer
center.
Procedures
The schedule for the genetic counselor was reviewed weekly for the upcoming week.
Once a patient was identified as meeting the inclusion criteria, they were contacted by the DNP
student, where project information and consent were discussed. If the patient consented to
participate in the project, the DNP student met them at their first visit to sign the consent and
complete a demographics questionnaire (see Appendix G) and the three project assessments.
Demographic data, including age, educational level, marital status, and ethnicity, were collected.
Consenting participants completed the knowledge, self-efficacy, anxiety, and depression
assessments before viewing an educational PowerPoint presentation (the project’s intervention).
The participants were given a printed copy of the educational slides and instructions on accessing
17

the video on the internet if they or any other family member wished to view it. The same preassessments and a brief program evaluation (post-survey) (see Appendix H) were completed at
their follow-up visit with the genetic counselor, approximately three to four weeks after the
initial appointment. This completed the patients' participation in this project. Participants also
had the option to complete all the surveys and assessments with pen and paper if they were
uncomfortable using the hand-held device. The instruments used to collect the above data
included (a) Breast Cancer Knowledge Questionnaire 27, (b) DASS-21, and (c) Generalized
Self-Efficacy Scale; these instruments are discussed below.
Project Intervention, Instruments, and Outcome Variables
At the initial visit, the participant viewed a short PowerPoint presentation (the
intervention) discussing different aspects of breast cancer and breast cancer risk. The
presentation included information on genes, genetic testing, and the genetic counselor's role.
Also discussed in the presentation were the myths around developing breast cancer, criteria for
establishing a high-risk patient, and lifestyle changes and screenings for risk reduction. At the
follow-up visit with the genetic counselor, which was approximately three to four weeks after the
initial appointment, the project leader met with the patient to complete the post-intervention
assessments.
The study variables included breast cancer genetics knowledge, self-efficacy, anxiety,
and depression. Three previously validated instruments were used in this project. The Breast
Cancer Genetics Knowledge Questionnaire is a 27-item instrument that assesses breast cancer
genetics knowledge (see Appendix D). Anxiety and depression were assessed using the 14-item
Depression, Anxiety, and Stress Scale (DASS) (see Appendix E). Lastly, the General SelfEfficacy (GSE) scale was utilized (see Appendix F). This project's outcome goals were to
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potentially see a change in knowledge, a change in anxiety and depression, and a change in selfefficacy regarding being at high risk for developing breast cancer.
Timeline
For this project, the proposal defense was completed in April 2021. Once the project
proposal was completed and approved, the project was submitted to the University’s IRB for
approval. After the appropriate IRB approvals were obtained, data collection began. The goals
were to start data collection in May 2021 and continue through December 2021. Data analysis
began in January 2022. The project was completed and defended in the Spring of 2022.
Resource Utilization
Resources for this DNP project included a genetic counselor at a large cancer center in
Southern Nevada who helped develop the PowerPoint intervention. In addition, the cancer center
practice manager assisted with scheduling the high-risk patients and helping the DNP student
with identifying potential study participants. The genetic clinic scheduler was also a team
member who helped screen potential patients and notified the DNP student. The DNP student
then reviewed the chart and contacted the patient to discuss the possibility of inclusion in the
study before their arrival for their appointment.
Data Analysis
Descriptive statistics were used to describe the demographic data of the sample, including
frequencies and percentages. The data were analyzed using the Statistical Package for Social
Sciences (SPSS) software. A dependent paired t-test, with the significance level set to 0.05,
determined if there was a statistical significance when comparing the outcome variables pre-and
post-the intervention.
Key Stakeholders

19

Key stakeholders for this project included this DNP student, the University’s graduate
advisory committee chair and members, , the cancer center's clinical director, executive director
of the cancer centers, and a medical oncologist and practice president for the cancer centers.
Further stakeholders included the patients, families, and additional providers at the clinics.
Organizational Assessment
The cancer center is the most extensive oncology practice in Nevada. They have 25
medical oncologists, nine radiation oncologists, and 11 advanced practice providers across seven
offices. Two of the advanced practice providers specialize in genetic counseling. There are very
few genetic counselors in Nevada; therefore, the counselors at the cancer center have a robust
practice.
Resources and Support
The educational video was developed in PowerPoint for ease of presentation and
uploaded to the internet. All information was created with the genetic counselor to ensure that it
was comprehensive. Educational materials and guidelines were generated from the National
Comprehensive Cancer Network, Myriad Genetics Laboratories, Invitae Laboratories, and the
genetic counselor’s education tools currently provided to patients during their initial visit.
Risks and Threats
For this project, one of the most significant risks was the possibility of not having enough
participants. Often, patients were scheduled to see the genetic counselor and not keep the
appointment. A potential threat for this project was the patients. Experience has shown that once
patients learn of a new medical issue, they immediately search the internet for information. Some
of the information available is very good, but some are biased. This unclear information can
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cause patients to have preconceived beliefs about their high-risk status and make it difficult if the
ideas and education differ significantly from what they believe.
Financial Plan
No financial needs were anticipated for this project, and no costs were incurred.
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Chapter V
Results
This chapter presents the results of this DNP Project, for which the purpose was to
determine if cancer risk education changes knowledge, self-efficacy, anxiety, and depression.
Results describing the participants' selection and demographics and the outcome variables of
knowledge, self-efficacy, anxiety, and depression are included.
Participant selection was initiated on June 11, 2021. The schedules for the genetic
counselor were reviewed daily from July 6, 2021, to December 14, 2021. The
exclusion/inclusion criteria described in Chapter IV were utilized during the schedules’ initial
screening. Potential participants who met the inclusion criteria were contacted by phone the day
before their genetic counseling appointment. The project process and goals were discussed
during the phone call, and participant questions were answered. Potential participants were then
given the option to agree to be included in the study or decline. Over the five months, 82
potential participants were identified. Of those 82 contacts, 31 agreed to participate in the
project, completed the pre-survey, and viewed the educational intervention. Of those 31, 22
participants fulfilled the task by completing the post-survey questionnaires and composing this
project's sample (N=22). The other nine participants either did not attend their follow-up
appointment or had a telehealth visit and did not complete the post-survey questionnaires.
Participant Demographics
Participants’ age ranged from 21 – 67 years, with a mean of 45.6 ± 11.0 years. All
participants were female; most had some college education and were married, White, had no
genetic counseling, and had their last mammogram in 2021 (Table 1).
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Table 1: Participants’ Demographic Characteristics (N= 22)
Characteristic

Frequency

Percentage

High School Diploma

6

27.3

Associate Degree

5

22.7

Bachelor’s Degree

3

13.6

Master’s Degree or Higher

7

31.8

Prefer Not to Answer

1

4.5

Single/Never Married

7

31.8

Married/Domestic Partner

14

63.6

Divorced

1

4.5

Education

Marital Status

Ethnicity
Black/African American

2

9.1

Asian/Pacific Islander

3

13.6

Hispanic/Latino

3

13.6

White/Non-Hispanic

14

63.6

No

20

90.9

Yes

2

9.1

Never

3

13.6

2020

1

4.5

2021

18

81.8

Previous Genetic Counseling

Last Mammogram
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Outcome Variables
The outcome variables for this project included knowledge and self-efficacy, anxiety, and
depression. The goal of the project was to see changes in knowledge, self-efficacy, anxiety, and
depression between the pre-and post-evaluation. Statistical differences pre and post-intervention
were noted only in Knowledge (p = 0.04) (Figure 1 and Table 2).

Figure 1 Knowledge Scores (n=22)

Table 2: Paired Sample Statistics from participants in an educational intervention (n=22)
Outcome
Variable

Mean/SD PreIntervention

Mean/SD PostIntervention

p-value

Knowledge

63.86±11.961

69.59±12.53

0.04

Self-efficacy

32.82±3.67

32.8±2.88

ns

Anxiety

6.45±6.442

5.18±4.30

ns

Depression

5.36±5.287

6.00±5.30

ns
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Table 3: Project Evaluation
Evaluation Questions and Possible Responses
Do you feel that the education you received
has helped with your understanding of your
high-risk status?
Yes
No

Do you feel that the new knowledge you have
has helped reduce your anxiety about your
high-risk status?
Yes
No

Do you feel this will also help you in
following the screening recommendations that
were made?
Yes
No

How many times did you watch the
educational video at home?
0
1
2

Did anyone in your family view the video?
Yes
No
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Frequency

Percentage

21
1
22

95.4%
4.5%
100.0%

19
3
22

86.4%
13.6%
100.0%

22
0
22

100.0%
0.0%
100.0%

12
9
1
22

54.5%
41.0%
4.5%
100.0%

5
17
22

22.7%
77.3%
100.0%

Chapter VI
Discussion and Conclusion
Breast cancer continues to be a significant health concern for women in the United States.
Genetics has become an essential part of managing those at high risk for developing breast
cancer. Patients who are considered high-risk for breast cancer go through many emotions when
they receive a recommendation for genetic counseling. These emotions can include decreased
self-efficacy, anxiety, and depression when undergoing genetic counseling and testing due to a
lack of knowledge. This Doctor of Nursing Practice project aimed to see if knowledge and selfefficacy could be improved and if anxiety and depression changed. following an educational
intervention regarding being at high risk of developing breast cancer.
This chapter presents a discussion of the results of this project related to the outcome
variables and how these results related to the literature and other issues impacting this project.
Variables, project barriers and limitations, project results and impact, project results and impact,
sustainability, dissemination, and the project conclusion are also included.
Variables
Data analysis from a paired samples t-test revealed no significant difference in selfefficacy, depression, and anxiety pre-and post- the intervention. The self-efficacy scores were
unchanged between the two assessment time frames, the depression scores slightly increased,
and anxiety was improved, but not significantly.
This author speculates that this could be due to multiple factors. One could be that
patients were experiencing these feelings about the initial genetic counseling visit where they
would have to review family history and determine if they did indeed need to have genetic
testing performed. At the follow-up visit, the participants were still experiencing their feelings
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about the upcoming review and interpretation of the genetic testing results. The participants may
have also been influenced by thinking about what additional surveillance they would have to
undergo to monitor their high-risk status.
The anxiety scores did show a slight but not clinically significant improvement when
comparing the pre-and post-intervention results. Data from the post-survey revealed that many
participants recognized that the educational intervention helped with anxiety. It is hypothesized
that this could be due to how the educational intervention explained the genetic counselor’s role
and the rationale for a visit better than what was presented by the referring provider when the
genetic counseling referral was made. The variable with the most clinical and statistically
significant change was knowledge. After viewing the educational PowerPoint intervention, the
project participants showed that they learned some basic tenets of breast cancer genetics.
Project Barriers and Limitations
Two main barriers could have affected the outcome of this DNP project. One is the
worldwide COVID-19 pandemic occurring during the project implementation phase. The Delta
and Omicron variant surges affected this phase by making potential participants weary of being
out in public and opting to cancel or reschedule their appointments. The Delta variant surge
occurred during July and August of 2021, and the Omicron variant occurred during December of
2021. If potential project participants chose to keep their genetic counseling appointment, many
opted for a telehealth visit, making them ineligible to participate in the study. The Delta and
Omicron COVID-19 pandemic surge also impacted the number of participants who completed
the project. Thirty-one participants were recruited and completed the pre-survey questionnaires,
but only twenty-two were able to complete the entire project.
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This project was also affected by time which caused the project to be underpowered. The
goal of the project was 120 participants. With only eight months to implement the project, there
was insufficient time to accrue enough participants to power the study which could have affected
the results. The time limit allowed an accrual of only 22 participants. Other factors included
vacation days taken by the genetic counselor during the implementation phase, which also
influenced the time limitations and the number of potential project participants.
Project Results and Impact
A data analysis review shows that the project addressed the statistical change in the
knowledge variable and a clinically significant improvement in anxiety. Since the self-efficacy
and depression scores did not change, the project did not impact these potential problems
experienced by the project participation population.
When preparing for this project, the literature review was extensive for the variables that
would be involved. Overall, 18 articles evaluated during the literature review revealed a direct
correlation between knowledge and anxiety about having a high-risk status. Eleven of the articles
reviewed found a correlation between increasing knowledge and decreasing anxiety. A clinically
significant correlation between knowledge and anxiety was seen in this project. Improving
understanding about being high-risk for breast cancer would help improve self-efficacy and
reduce anxiety and depression regarding their status.
The project results were not conclusive when evaluating the depression variables.
According to a study done by Listol et al. (2017), patients with a BRCA mutation felt alone with
their concerns, causing depressive symptoms. The literature review evaluated five articles, and
all five found that depression is common in someone who has a high-risk status. Listol (2017),
Nakamura et al. (2020), Weihs et al. (2018), Kim et al. (2017), and Doubova et al. (2020) all had
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improvements in depression following their proposed educational intervention, while this project
saw a slight change in the depression score. These results could have influenced the upcoming
appointment for genetic testing results, and the study itself was limited by time and an
underpowered study.
The literature review for self-efficacy included 18 articles where most of the findings
revealed that self-efficacy improved, and anxiety decreased as participant knowledge was gained
on a particular subject. The only article that did not show a clinical significance in improving
self-efficacy following an educational intervention was Antill et al. (2006). These findings are
similar to the findings of this project, where the self-efficacy scores were the same pre-and postintervention. These findings could result from the participants feeling comfortable with their
decision to see the genetic counselor and be evaluated.
The conceptual framework for this project is based on Albert Bandura’s Social Learning
Theory (Badura, 1977). He believed that “if people believe they can exercise control over the
occurrence of events that can be injurious, they will not fear them” (Badura, 1983). With the
significant change in the knowledge variable, this author would speculate that the previous
statement is true. When the variables of self-efficacy, depression, and anxiety are added to the
mix, it does not seem to hold as the only variable that had any change in the positive direction
was anxiety. There was no change in self-efficacy and an adverse change in the depression
scores. These variables might have resulted differently if the educational intervention was more
detailed or based on a needs survey about genetic counseling education.
This author feels that the study impacted patient outcomes based on the clinical and
statistically significant change seen in the knowledge variable. Having more information about
genetic counseling, a purpose for genetic testing, and the interpretation of the results is helpful in
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any situation regarding someone’s health risks. This project has impacted if even one of the
participants follows through with the recommended screenings to help monitor breast cancer
development.
Sustainability
This project could easily be sustained and become part of the genetic counseling visit.
The education intervention is a 10-minute PowerPoint presentation that covers topics in greater
depth than generally discussed at the visit. Since most genetic counseling visits are scheduled for
sixty minutes, the presentation could easily be incorporated. Also, the information in the
PowerPoint might help generate more meaningful questions and discussions during the genetic
counseling visit.
Dissemination
The data and results from this DNP project will be presented at the Western Institute of
Nursing’s 2022 Research Conference on April 8, 2022, during the morning poster session.
During this time, this author will be available to discuss the aspects of the project and the
outcomes with interested parties. The conference presentation may also generate interest for
these other parties to utilize an educational intervention with their genetic counseling visits. Even
though there is no plan for further scholarly activities in this area, this author plans to continue to
put the knowledge gained for her DNP degree in place at her current practice. One of her initial
focuses will be staff recruitment and retention.
Conclusion
Breast cancer continues to be a significant health concern for women in the United States.
As we learn more about the genetics of the disease and how it can influence a woman’s risk for
developing cancer, we must provide education about that risk. Having a high risk for breast
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cancer can cause decreased self-efficacy, depression, and anxiety. This project aimed to
determine if the variables of self-efficacy, anxiety, depression, and knowledge would be affected
by having participants view an educational PowerPoint about breast cancer genetics.
More research needs to be done in this arena as the understanding of cancer genetics
grows and becomes more complicated for the layperson. Developing education resources and
tools for this population is imperative for helping high-risk patients undergo genetic counseling.
Research should then be focused on the best way to provide these educational resources and
tools for this population to improve their understanding of their risk. In the long term, this could
improve the patient’s self-efficacy and significantly decrease their anxiety and depression about
being high-risk, ensuring they are more compliant with the recommended screenings for
monitoring.
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Appendix A
Search Tables
Table 1A
CINAHL Search Table 1
High
Risk
for
Breast
Cancer
1668

BRCA1
and
BRCA2

Risk
Risk
Cancer
Cancer
Reduction
Reduction Screening
Screening
Strategy
Adherence Adherence

1243

13

5550

24394

111

#1 and #2

#7 and
#3

#7 and
#4

#8 and
#5

#9 and
#6

#10
and
#11

151

0

17

0

1662

1670

Table 2A
Cochrane Search Table 1
High
Risk for
Breast
Cancer
82

BRCA1
and
BRCA2
3

Risk
Risk
Cancer
Cancer
Reduction
Reduction Screening
Screening
Strategy
Adherence Adherence
41

225

21

9

32

#1 and
#2

#7 and
#3

#7 and
#4

#8 and
#5

#9 and
#6

#10 and
#11

1

1

1

15

13

6

Table 3A
PUBMED Search Table 1
High
Risk for
Breast
Cancer
1067

BRCA1
and
BRCA2

Risk
Risk
Cancer
Cancer
Reduction
Reduction Screening
Screening
Strategy
Adherence Adherence

213

341

2690

178

140

#1 and
#2

#7 and
#3

#7 and
#4

#8 and
#5

#9 and
#6

#10 and
#11

19

20

1121

1

21

0

#1 and
#2

#7 and
#3

#7 and
#4

#8 and
#5

#9 and
#6

#10 and
#11

3538

159

1807

2
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Table 4A
Scopus Search Table 1
High
Risk for
Breast
Cancer
48796

BRCA1
and
BRCA2

Risk
Risk
Cancer
Cancer
Reduction
Reduction Screening
Screening
Strategy
Adherence Adherence

1747

5631

240976

880

3004

Table 5A
CINAHL Search Table 2
Cancer

Anxiety

Education/Knowledge

#1, #2, and #3

445415

101749

684183

1248

33

#4 and Breast
Cancer
94334

#2, #3, and #5
345

#7 and highrisk/BRCA1/2
23

Table 6A
Cochrane Search Table 2
Cancer

Anxiety

Education/Knowledge

#1, #2, and #3

1023

529

636

20

Cancer

Anxiety

Education/Knowledge

#1, #2, and #3

1078527

115503

470041

2865

#4 and Breast
Cancer
149

#2, #3, and #5
8

#7 and highrisk/BRCA1/2
3

Table 7A
Scopus Search Table 2
#4 and Breast
Cancer
527068

#2, #3, and #5
867

#7 and highrisk/BRCA1/2
172

Table 8A
PUBMED Search Table 2
Cancer

Anxiety

Education/Knowledge

#1, #2, and #3

4258919

254212

1828690

3451

34

#4 and Breast
Cancer
901

#2, #3, and #5
871

#7 and highrisk/BRCA1/2
50

Appendix B
Table 1B
Evidence Table
Citation

Sampling/Setting

Research Design

Data Analysis

Antill et al.
(2006).
Screening
behavior in
women at
increased
familial risk for
breast cancer.
Familial Cancer,
5, 359 – 368.

Sample:
N = 266
participants with
no personal
history of cancer
but either
high/moderate
risk based on
genetic pedigree

Two sources:
subjects
answered a selfreport
questionnaire and
data were
collected from
each subject's
medical record.

Fisher's exact
test
Blyth-StillCasella
Method

Setting:
Data collected
Multicenter study regarding
demographics,
family history
and risk
assessment,
surveillance
recommendation,
risk perception,
and impact of
events

MantelHaenszel ChiSquare test
Monte Carlo
Estimation

No significant
differences for
demographics
For breast selfexam no
significant
association
between
adherence and
risk category (P
= 0.57)
For clinical
breast exam no
significant
difference
between
moderate and
high-risk groups
in adherence
(P=0.62)

Reviewed
practices of

For
mammography
35

Level of
Evidence

Findings
4

Comments
Looked only at
familial risk not
any genetics
Did include all
current
guidelines for
screening but no
surgery options
Limited results
since was a selfreport to
determine
adherence
High risk defined
at estimated
lifetime risk of
>50%
Moderate risk
defined as >25%

Citation

Sampling/Setting

Research Design

Data Analysis

doing CBE, BSE,
and mammogram

Bredart et al.
(2011). Anxiety
and specific
distress in
women at
intermediate and
high risk of
breast cancer
before and after
surveillance
versus standard
mammography.
PsychoOncology, 21,
1185-1194.

Sample:
N=1561
participants aged
20 – 70 with no
clinical signs of
breast cancer, no
ongoing breast
cancer treatment,
no metastasis, no
bilateral
mastectomy, and
differed in terms
of objective
breast cancer
risk.
Setting:
21 centers in
France
experienced in

Subjects were
mailed a selfreported
questionnaire one
week prior to
MRI and a
second selfreport
questionnaire 15
days to 3 months
after MRI

Level of
Evidence

Findings
the results were
mixed with most
adherence seen in
the older
population and
number of firstdegree relatives
affected by breast
cancer

Multiple
regression
analysis
Hierarchical
multiple
regressions

Data collected
included patient
demographics,
breast cancer-risk
perception
Study focused on
psychological
outcomes of
36

Demographic
among all
participants was
not significantly
different
The two groups
(Mx and MRI)
were
significantly
different:
MRI was
younger, higher
level of
education, higher
risk perception,
more frequent
ultrasound and
less frequent
personal history
of breast cancer

Comments
Also looked at
over and under
screening
practices

4

Overall anxiety
over risk
perception was
higher in all
populations.
Older women
had higher STAIState anxiety
scores.
MRI group:
women with
demonstrated
genetic mutation,
non-tested
women with
FDR with genetic
mutation, women
with a probability
of genetic
mutation of at

Citation

Buchanan et al.
(2017).
Adherence to
recommended
risk management
among
unaffected
women with a
BRCA mutation.
Journal of
Genetic

Sampling/Setting

Research Design

breast MRI
techniques

additional
surveillance with
MRI in women at
high risk for
breast cancer

and more
frequent
abnormal
surveillance
results

Tools Used:
STAI-State
Anxiety

Anxiety levels
considered to be
low to moderate

Impact of Event
Scale

Mx group has
significantly
higher mean
scores of STAI –
State Anxiety
and IESAvoidance than
the MRI group

Sample:
N = 97
unaffected BRCA
mutation carriers
that had genetic
counseling at
least one year
prior to survey
Setting:
Self-reported
questionnaires

Cross-sectional,
single group to
assess adherence
to current
guidelines,
factors associated
with adherence
and common
reasons for
performing and
not performing

Data Analysis

Descriptive
statistics
Dichotomous
variables
Bivariate and
multivariate
regression
models

37

Level of
Evidence

Findings

Adherence
exceeded 50%
with the rates
greater than 75%
in women over
40

Comments
least 40% or
mutation of at
least 80%
Mx group:
personal history
of pathologic
breast lesions or
breast cancer
between 40 – 50,
no FMH, with
one FDR with
breast cancer
between 50 – 70,
or could not do
MRI

6

Many factors
influence
adherence
Looked at
behaviors in
general
Better genetics
knowledge
seemed to help
adherence

Citation

Sampling/Setting

Counseling, 26,
79-92.

Research Design

Data Analysis

recommended
risk management

Cox & Snell
Method

Level of
Evidence

Findings

Comments
Their theory
about the HBM
was not proven

Fisher's exact
test

Limited due to
design
Also looked at
over and under
screening
practices
Cabrera et al.
(2010). The
impact of genetic
counseling on
knowledge and
emotional
response in
Spanish
population with
family history of
breast cancer.
Patient
Education and
Counseling, 78
(3), 382-388.

Sample:
N =212
participants with
family history of
breast cancer,
over 18 years of
age, and ability
to read/write
Spanish

Setting:
Self-report
questionnaires
pre and post
genetic
counseling

Self -report
questionnaires to
review
demographics,
knowledge about
breast cancer,
psychological
measures,
subjective risk
assessment, risk
assessment, and
quality of life

Descriptive
Statistics

Tools Used:
HADS, Cancer
Worry Scale,
EuroQuol 5,
Tyrer-Cuzick

Paired t-test

Chi-Square
McNemar's
Test
ANOVA
followed by
post hoc
Fisher's test

Spearman's
Correlation

38

Demographic
analysis showed
most participants
were married and
had children
Mean knowledge
scores (risk
perception,
education) were
significantly in
all groups after
receiving
counseling when
compared to preintervention
scores.

4

Shows that
intervention of
genetic
counseling seems
to improve
cognitive aspects
Some cultural
impact on the
lack of
perception
adjustment
Women felt after
counseling felt
that it could help
their family
members make

Citation

Sampling/Setting

Research Design

Data Analysis

risk assessment
model

Repeated
measures
ANOVA

Level of
Evidence

Findings
Cancer worry
decreased
significantly after
counseling
intervention in all
groups

Comments
better decisions
about health care

No improvement
seen in perceived
risk vs. estimated
risk after
counseling visit
Drukteinis et al.
(2013). Beyond
mammography:
New frontiers in
breast cancer
screening.
American
Journal of
Medicine, 126,
(6), 472-479.

Setting:
Reviewed current
standard
recommendations
for breast
screening versus
new techniques

Green et al.
(2004). Effect of
a computerbased decision
aid on

Sample:
N = 211

Reviewed
mammography
on patients with
dense breast
versus other
imaging
modalities

None

Although
mammogram is
gold standard, in
women with
dense breasts
there may be
false positives
leading to
increase biopsies
leading to
increase patient
anxiety

6

Recommend that
imaging be based
individually and
not just
mammogram on
all patients, if
patient has dense
breast should
look at other
options that best
suit the
individual

Descriptive
statistics for all
variables

Comparable
demographics
between both
groups

1

Findings show
that an
interactive
computer
program was

Looked at high
risk patients

Setting:

Randomized
controlled trial
conducted from
May 2000 to
September 2002

t-test
39

Citation

Sampling/Setting

Research Design

knowledge,
perceptions, and
intentions about
genetic testing
for breast cancer
susceptibility.
Journal of the
American
Medical
Association, 292,
(4), 442-452.

Outpatient clinics
offering genetic
counseling at 6
US medical
centers

with 2 groups:
low-risk and
high-risk
Objective to
compare the
effectiveness of a
computer-based
decision aid with
standard genetic
counseling for
educating women
about BRCA1/2
testing

Data Analysis
Repeated
measures
ANOVA
Chi-square
Fisher exact
test
Likert Scale

Level of
Evidence

Findings
Knowledge
scores increased
for both groups
after counseling
but was higher in
the computer
group

more effective
than standard
counseling for
increasing
knowledge.
Counselors were
more effective in
reducing a
woman's anxiety
and facilitating
more accurate
risk perceptions
than the
computer
program.

Perception of risk
decreased
significantly after
either
intervention
Mean state
anxiety scores
were reduced by
counseling

Grimm et al.
(2019).
Frequency of
breast cancer
thoughts and
lifetime risk
estimates: A
multi-

Sample:
N = 2747
Setting:
Participants were
from 5 medical
centers

Survey
performed before
their
mammogram to
quantify women's
personal estimate
of breast cancer
risk and

State Anxiety
Scale
Cronbach α
Likert scale
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Women reported
up to six
thoughts of
cancer on
average in prior
month

Comments

Interactive
computer
program should
be used a
supplement only
4

Demographics
played a large
part in risk
perception

Citation

Sampling/Setting

institutional
survey of women
undergoing
screening
mammography.
Journal of the
American
College of
Radiology, 16,
(10), 1393-1400.

Haas et al.
(2005).
Perceived risk of
breast cancer
among women
of average and
increased risk.
Journal of
Women's Health,
14, (9), 845-851.

Research Design

Data Analysis

frequency of
breast cancer
thoughts in the
prior month

Wilcoxon's
rank-sum test

Notified of 12%
lifetime average
risk and asked to
estimate their
personal risk
both subjectively
and objectively
Sample:
N = 1619 women
aged 40-74 years
with no history
of breast cancer
identified
through the San
Francisco
Mammography
Registry

Survey to
examine factors
associated with
perception of
breast cancer risk
among women at
average and high
objective risk.
Study collected
demographics
and used the Gail
Setting:
model to
Phone interview
determine
from March 2002 participants
to July 2003
breast cancer risk
(risk score of at
least 1.67% were

Spearman's
correlation
coefficients

Findings

Level of
Evidence

Comments

More frequent if
personal/family
history, greater
anxiety, and
genetic testing
Women without
risks factors had
1.4 thoughts per
month which
correlated to
baseline anxiety

Frequency
distributions
Multivariate
logistic
regression
models
c-statistic

Approximately
4
2/3 of
participants had
an average risk –
these women
accurately
perceived their
risk at 72%
whereas the highrisk only had
43.1% accuracy
Younger women
than older
women were
more likely to
perceive they

41

As expected,
those women
with established
risk factors,
particularly an
FDR with breast
cancer, were
more likely than
women without
to accurately
perceive they
were at an
increased risk
Need to make
sure there is
understanding of
risk to make

Citation

Sampling/Setting

Research Design

Data Analysis

considered high
risk

Findings
were at perceived
risk
Women with a
family history
regardless of risk
were more likely
to overestimate

Issacs et al.
(2002). Breast
and ovarian
cancer screening
practices in
health women
with a strong
family history of
breast or ovarian
cancer. Breast
Cancer Research
and Treatment,
71, 103 – 112.

Sample:
N = 216 females
aged 30 and
older who were
unaffected with
cancer and were
either members
of families with
at least a 10%
probability of
carrying
BRCA1/2 or have
a first degree or
second degree
relative with a
documented

Data collected on
demographic
characteristics,
clinical
characteristics,
and
psychological
factors
Also included
practices of
obtaining a
clinical breast
exam and
mammogram

Likert Scale
Descriptive
statistics
Bivariate
analysis
Multivariate
analysis
Chi-square

Prior breast
biopsy and h/o
abnormal
mammogram no
associated with
perception of risk
Relatively low
4
adherence rate to
mammography in
older women and
no real
significance in
adherence with
the other factors
reviewed

Level of
Evidence

Comments
informed
decisions about
screening and
options for risk
reduction

5-year study
Looked at all
methods of
screening
First study done
in the US
examining
adherence to
screening
recommendations
Revealed that
better education
is needed overall

42

Citation

Sampling/Setting

Research Design

Data Analysis

Meta-analysis
looking at
perceived risk to
predict adoption
of healthprotective
measures

Means and
SDs

Level of
Evidence

Findings

Comments

BRCA1/2
mutation
Setting:
Telephone
Interviews
Katapodi et al.
(2003).
Predictors of
perceived breast
cancer risk and
the relation
between
perceived risk
and breast cancer
screening: a
meta-analytic
review.
Preventative
Medicine, 38,
388-402.

Sample:
N = 42 studies
between 1985 –
2004

t tests

Women do not
have an accurate
perception of
their risk for
breast cancer

chi-square
F tests
r correlations
frequencies or
proportions
P values
2x2 tables

Women with a
positive family
history perceive
their risk to be
higher
Only a few
studies to look at
demographics
and perceived
risk
A positive
correlation
between
perceived risk
and intensity of
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1

Looked at how a
patient's
perceived risk
belief factored
into their
adherence to
screening
Recommended
continuing
development
strategies to
reduce risk and
change
perception of risk
Believes that
relationship
between
perceived risk
and screening
behavior is
complex

Citation

Sampling/Setting

Research Design

Data Analysis

Level of
Evidence

Findings

Comments

emotional
response
A positive
association
between
perceived risk
and adherence to
mammography
screening
Women with
HBOC perceived
their risk to be
higher
Lobb et al.
(2006).
Development of
a communication
aid to facilitate
risk
communication
in consultations
with unaffected
women from
high risk breast
cancer families:
A pilot study.
Journal of
Genetic

Sample:
N = 27
Setting:
Self-report
questionnaires 1
week prior to
genetic
counseling
session and 2
weeks after

To determine if
adding a
standardized
communication
aid would
increase
knowledge and
risk
communication
during a visit
with a genetic
counselor
Data collected:

Descriptive
Statistics
Change scores
Chi-square
Student t-tests
Mann-Whitney
U-tests
Repeated
Measures
ANOVA
44

Significant
difference in
knowledge
scores between
baseline and
follow-up
No significant
difference
between total
knowledge
scores between
any groups

4

Only study to
compare to
previous RCT
done by same
author
Also, only study
to evaluate
practitioner
outcomes about
the use of aid

Citation
Counseling, 15,
(5), 393-405.

Sampling/Setting

Research Design

Data Analysis

Demographics,
breast cancer
genetics
knowledge, risk
perception, breast
cancer anxiety,
general anxiety
and depression,
satisfaction with
genetic
counseling
session,
satisfaction with
risk
communication
aid

Findings
No significant
differences in the
change scores in
general anxiety
or breast cancer
specific anxiety
Most women
accurately
estimated the
population risk of
breast cancer
Majority of
women were
satisfied with the
genetic
counseling
session
Majority of
women found aid
extremely or very
useful in
understanding
breast cancer
genetics and in
understanding
their personal
risk

45

Level of
Evidence

Comments

Citation
Lobb et al.
(2005).
Differences in
individual
approaches:
Communication
in the familial
breast cancer
consultation and
the effect on
patient
outcomes.
Journal of
Genetic
Counseling, 14,
(1), 43-53.

Sampling/Setting

Research Design

Data Analysis

Sample:
N = 150

Data collected by
self-reported
questionnaire 2
weeks prior to
and 4 weeks after
genetic
counseling

Descriptive
Statistics

Setting:
Participants were
from 10 familial
cancer clinics
seen between
November 1998
– April 2000.

ANOVA
Kruskal-Wallis
Chi-square

Participants
stratified
according to
affected or
unaffected
women

Bonferroni
Adjustment
Power
Analysis

Consultations
were recorded to
compare
recommendations
and education
provided during
the consultations

87% of women
wanted as much
information as
possible
12% wanted only
information
needed to deal
with immediate
issues
1% wanted
additional
information only
if it was good
news
DecisionMaking:
88%
collaborative
decision making
5% decision
made by clinician
7% make their
own decision
No relationship
for decision
making based on
age, education, or

Measures
included:
demographics,
objective risk,
expectations,
coping style,
decision making
preference
46

Level of
Evidence

Findings
1

Comments
Study that looks
at the participants
and the
counseling
session and how
information and
recommendations
were provided
By combining
both teaching and
counseling might
see an
improvement in
both knowledge
and anxiety about
perceived risk.
Need more
consistency in
consultations

Citation

Sampling/Setting

Research Design

Data Analysis

Sample:
N=0
Setting:
Review of
guidelines for
high risk patients

Evaluated the
role of the
oncology nurse
in health
promotion
regarding high
risk and
education

Level of
Evidence

Comments

professional
status

Tools used:
MonitoringBlunting Style
Scale, Cassileth
Information
Styles
Questionnaire,
Impacts of
Events Scale,
HADS, Breast
Cancer Genetics
Knowledge

Manley Conto et
al. (2001). Risk
factors and
health promotion
in families of
patients with
breast cancer.
Clinical Journal
of Oncology
Nursing, 6, (2),
1-5.

Findings

Monitoring:
56% high
monitors
45% low
monitors
Significant
differences in
styles of
consultation and
how data was
delivered
None

47

Reviewed the
7
ability of
oncology nurse
to provide
education about
high risk and
help promote
adherence to
screening
recommendations
such as SBE,
CBE,
mammography,
and genetic

Expert opinion
paper
Encourage the
expert level
oncology nurse
to help promote
health behaviors
and provide
guidance to help
reduce anxiety

Citation

Sampling/Setting

Peshkin et al.
(2002).
Utilization of
breast cancer
screening in a
clinically based
sample of
women after
BRCA1/2 testing.
Cancer
Epidemiology,
Biomarkers, &
Prevention, 11,
1115 – 1118.

Sample:
N = 107 women
who self-referred
for genetic
counseling that
were > 25 with
no history of
cancer or
prophylactic
mastectomy and
had definitive
BRCA1/2 results

Phillips et al.
(2006). Riskreducing
surgery,
screening, and
chemoprevention
practices of
BRCA1 and
BRCA2 mutation
carriers: a
prospective
cohort study,

Sample:
N = 142
unaffected
female mutation
carriers

Setting:
Telephone
Interview

Setting:
Self-reporting
questionnaire
mailed to their
home

Research Design

Data Analysis

Patients were
Chi-square
tested for
BRCA1/2 and
then received
counseling.
They were then
contacted via
phone one, six,
and 12 months
after to ask
whether they had
undergone any
surgery and if not
had they obtained
a CBE and
mammogram
Participants
enrolled in
kConFab study
and had to be
carriers of a
pathogenic
mutation in
BRCA1 or
BRCA2,
complete
questionnaire at 3
years after study

Level of
Evidence

Findings
counseling when
warranted.
No significant
difference for
carriers/noncarriers based on
demographics

4

Significant
results predictor
of obtaining a
CBE after receipt
of test results

Comments

Hard to tell what
statistics they
used Showed
different result
for mammogram
utilization in the
older population
than other studies
Question if
guidelines for
testing high risk
women under 35
should be
changed

No significant
difference for
mammography
utilization

Exact binomial
confidence
intervals (CIs)

59% of
participants had
attended an FCC

Fisher's exact
p-values

7% underwent
Bilateral
mastectomy

Mention MRI as
risk reduction
measure

Only one
underwent
chemoprevention

Noted that
women who
know and
understood their

Linear logistic
regression
Parsimonious
models
48

4

Only study to
include
chemoprevention

Citation

Sampling/Setting

Clinical
Genetics, 70,
198-206.

Research Design

Data Analysis

entry, and not
have personal
history of
invasive cancer.
Data collected:
demographics,
mutation status,
and risk
management
Also included
practices of
obtaining BSE,
CBE,
mammogram,
risk management,
and
chemoprevention

Price, et al.
(2010).
Predictors of
breast cancer
screening
behavior in
women with a
strong family
history of the
disease. Breast

Sample:
N = 748
unaffected
women with a
strong family
history of breast
cancer.
Setting:

Data collected on
self-reporting
questionnaire
included:
demographics,
cognitive
representation of
perceived risk,
emotional
representation,

Findings

chi-square
multi-nominal
logistic
regression

Comments

23% undergoing
annual breast
exams

mutation more
likely to keep up
with screenings

Only one had
regular breast
MRI

Had high
response rate of
75% to mailed
questionnaires

Women aware of
their mutation
status were 7
times more likely
to undergo riskreducing surgery
and undertake all
screening
practices except
BSE

Analysis of
variance

Level of
Evidence

Screening
4
practices
statistics: 74%
screened
accordingly, 16%
under-screened,
10% overscreened.

No reminder
system available
to keep women
aware of
screening needs
Included women
that had
undergone
genetic
counseling
More strategies
needed such as
education to help
reduce number of
under screening
and over
screening
Perceived risk of
developing breast
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Citation

Sampling/Setting

Cancer Research Women
and Treatment,
participating in
124, 509-519.
the kConFab
Clinical Followup study and
kConFab
Psychosocial
study were
mailed selfreporting
questionnaires

Research Design

Data Analysis

and concordance
with screening
guidelines
Included
practices of
obtaining a CBE,
doing BSE, and
mammogram

Level of
Evidence

Findings
Includes
breakdown of
each method with
results showing
same and based
on age

Comments
cancer is a
motivating factor
in screening
practices
Genetic
counseling
should also be
offered to this
high-risk group
Looked at factors
that contribute to
over and under
screening

Price et al.
(2007).
Predictors of
cancer worry in
unaffected
women from
high risk breast
cancer families:
Risk perception
is not the
primary issue.
Journal of
Genetic
Counseling, 16,
635 – 644.

Sample:
N = 1744
Setting:
Women aged 18
– 75 years
participating in
kConFab.
Mailed
information and
self-report
questionnaires

Data collected to
evaluate cancer
specific worry,
perceived
lifetime risk,
demographics
including family
history and
biological
variables,
psychosocial
variables for
anxiety

Descriptive
Statistics
Spearman's
coefficient

Participants with
FM and/or
genetic testing
had the strongest
correlation with
cancer worry or
perceived risk
Levels of cancer
worry are low in
unaffected
women
Women's anxiety
or worry about

Tools Used:
50

4

Cancer risk
calculated using
the Tyrer-Cuzick
algorithm
Knowledge of
mutation
revealed to be a
complex
construct

Citation

Sampling/Setting

Research Design

Data Analysis

Life Event and
Difficulties
Schedule,
HADS, Life
Orientation Test,
Duke-UNC Life
Orientation Test

Level of
Evidence

Findings

Comments

breast cancer is
influenced by a
range of factors
and if they have
generalized
anxiety
Not having
family support
also increase
anxiety

Rosenthal et al.
(2016).
Increased
identification of
candidates for
high-risk breast
cancer screening
through
expanded
genetic testing.
Journal of the
American
College of
Radiology, 14, 4,
561-568.

Sample:
N = 9641 women
who had
undergone
expanded genetic
testing
Setting:
Data derived
from clinical
testing ordered at
Myriad Genetic
Laboratories for
194,1078 female
patients between
9/2013 – 2/2016.

To quantify the
impact of testing
for genes beyond
BRCA1/BRCA2
and the extent to
which mutation
carriers in the
genes would
have been
identified as
candidates for
enhanced
screening based
on family history
alone

Claus Model to BRCA1/BRCA2
assess lifetime accounted for
risk
59.1% of all PVs
38.8% PVs were
in ATM, CHEK2,
or PALB2 Only
24.7% of all
women with PVs
found in any
gene reached the
>20% lifetime
risk threshold
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6

Looked
specifically at
genetic mutations
to see if
expanded
screening is
needed
Recommended
that expanded
screening is
needed to find
those women
who need
increased
screening and
would not have
been identified

Citation

Sampling/Setting

Research Design

Data Analysis

Level of
Evidence

Findings

Comments
based on family
history alone

Roussi et al.
(2010).
Enhanced
counselling for
women
undergoing
BRCA1/2
testing: Impact
on knowledge
and psychosocial
distress – results
from a
randomized
clinical trial.
Psychology and
Health, 25, (4),
401-415.

Sample:
N = 134
Setting:
Participants were
recruited from
the Family Risk
Assessment
Program at Fox
Chase Cancer
Center between
May 1998 –
October 2000
Telephone
contact followed
by self-report
questionnaire

Data collected at
baseline included
background
variables:
demographics,
cancer history,
trait, anxiety, and
attentional style,
and outcomes
variables:
knowledge
intrusive
ideation, and
cancer-related
worry
Knowledge reassessed 1 week
after intervention
and 1 week
following test
result (if opted to
have genetic
testing done);
intrusive ideation
and cancerrelated worry reassessed 1-week

Linear
regression
analysis
Two-way
interactions
Chi-square
Two-tailed ttests
Descriptive
statistics
Pearson's
coefficient

Women who
attended all
sessions were
more
knowledgeable
Women who did
not complete
final
questionnaires
scored lower on
trait anxiety at
baseline
Those with less
education tended
to have more
anxiety
Those in the EC
group had lower
levels of
intrusive ideation
1-week post test
result
Women in the
EC group
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4

Intervention and
Control groups:
EC – cognitive
affective
preparation
All participants
met for predisclosure
session
EC group met
with Health
educator after
genetic
counselling
session
Educational aids
along with
counseling
sessions
improves
experience
overall

Citation

Sampling/Setting

Research Design

Data Analysis

following
disclosure of test
results

Sample:
N=0
Setting:
None

Expert opinion
on a Risk
Assessment and
Management
Program for high
risk patients

Comments

demonstrated
greater
knowledge
consistent with
hypothesis and
literature

Tools used:
State-Trait
Anxiety
Inventory, Miller
Behavioral Style
Scale, Impact of
Events Scale

Sciaraffa et al.
(2020). Breast
cancer risk
assessment and
management
programs: A
practical guide.
The Breast
Journal, 26,
1556-1564.

Level of
Evidence

Findings

No significant
results regarding
impact of
intervention on
cancer-related
worry
None

53

Described the
components and
information
necessary to
build a
comprehensive
program for
management of
high-risk breast
patients: target
population,
referrals,
marketing,
administrative
considerations
roles and
responsibilities,

7

Reviewed the
GINA laws
Table with all
breast cancer risk
assessment
models –
organized
according to
clinical decisionmaking
Breaks the visit
experience down
into 3 parts:
Information
gathering, the

Citation

Sampling/Setting

Research Design

Data Analysis

Level of
Evidence

Findings
research
opportunities, the
visit experience,
and follow-up
plan

Stalmeier et al.
(2009). Concise
evaluation of
decision aids.
Patient
Education and
Counseling, 74,
(1), 104-109.

Sample:
N = 390
participants that
had BRCA1/2
mutation
Setting:
In the clinic and
at home

2 Decision aids
were used:
1) Brochure
and video
reviewed
at home
2) 3 sessions
with
trained
research
assistant
with an
interval
of 1-2
weeks

Tools used:
Decision
Evaluation
Scales, Center
for
Epidemiologic
Studies
Depression
Scale,
Spielberger
State-Trait
Anxiety
Inventory,
Impact of
Event Scale

Data collected:
Satisfaction with
quality of
information,
subjective
knowledge,
amount of
information,
decision

Likert Scale
ANOVA

54

Two different
decision aids
affected separate
factors –
The second had
positive longterm effects but
not short term
Short
questionnaires
are more
desirable

Comments
risk profile, and
the risk
management plan

4

Dutch study
Did not include
patients that had
metastatic
disease, had
undergone
surgery, or had
been treated for
cancer less than
one month before
blood sampling

Citation

Tang et al.
(2009). Women's
mammography
experience and
its impact on
screening
adherence.
PsychoOncology, 18,
727-734.

Sampling/Setting

Sample:
N = 397 women
obtaining
screening
mammograms
Setting:
Telephone
interview

Research Design
evaluation scales,
depression,
anxiety, distress,
general health,
strength of
preference,
weighing pro and
cons
To analyze a
women's
mammography
experience,
examine the rates
of repeat
mammography,
and to identify
the significant
predictors of
repeat testing
within 12 and 18
months of index
mammogram.
Data collected on
satisfaction with
clinical services,
physical
experience,
psychological
experience, and
communication
with clinic staff.

Data Analysis

Logistic
regression
models
Likert Scale
Cronbach's
alpha

55

Findings

Tang et al.
(2009). Women's
mammography
experience and
its impact on
screening
adherence.
PsychoOncology, 18,
727-734.

Level of
Evidence

Sample:
N = 397
women
obtaining
screening
mammograms
Setting:
Telephone
interview

Comments

To analyze a
women's
mammography
experience,
examine the rates
of repeat
mammography,
and to identify
the significant
predictors of
repeat testing
within 12 and 18
months of index
mammogram.
Data collected on
satisfaction with
clinical services,
physical
experience,
psychological
experience, and
communication
with clinic staff.

Citation

Sampling/Setting

Research Design

Data Analysis

Tinley, et al.
(2004).
Screening
adherence in
BRCA1/2
families is
associated with
primary care
physician's
behavior.
American
Journal of
Medical
Genetics, 125A,
5-11.

Sample: N = 112
women who
tested positive
for BRCA1/2 and
their female
relatives who
have not been
tested but are
known to have a
50% risk of
having the
mutation

Data collected
included
screening
behaviors over
last 2 years, risk
perception,
cancer specific
distress,
adherence,
determinants,
specific barriers,
and cancer
history to provide
an assessment of
long-term breast
cancer screening
with adherence
Looked at
practice of
obtaining CBE,
SBE, and
mammogram

Descriptive
statistics

Setting: Mailed
self-reporting
questionnaires

chi-square test
of
independence
Fisher’s Exact
test
Mantel
Haenszel P
Breslow-Day
Wilcoxon
Rank Sum
Wald Test
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Findings
Tinley, et al.
(2004).
Screening
adherence in
BRCA1/2
families is
associated with
primary care
physician's
behavior.
American
Journal of
Medical
Genetics, 125A,
5-11.

Level of
Evidence
Sample: N =
112 women
who tested
positive for
BRCA1/2 and
their female
relatives who
have not been
tested but are
known to have
a 50% risk of
having the
mutation
Setting:
Mailed selfreporting
questionnaires

Comments
Data collected
included
screening
behaviors over
last 2 years, risk
perception,
cancer specific
distress,
adherence,
determinants,
specific barriers,
and cancer
history to provide
an assessment of
long-term breast
cancer screening
with adherence
Looked at
practice of
obtaining CBE,
SBE, and
mammogram

Appendix C
Table 1C
Synthesis Table
Recommended
Screening
Mammo, CBE,
SBE

Anxiety/Per
ceived Risk
X

X

X

Questionnaire

MRI

X

X

X

Questionnaire

Mammo, CBE,
SBE

X

Study

Setting

Antill et
al.

Questionnaire

Bredart, et
al.
Buchanan,
et al.

Cabrera, et
Questionnaire
al.
Drukteinis,
et al.

Green, et
al.

Grimm, et
al.

Data Review
Outpatient
Clinic –
Interactive
computer or
one-on-one
counseling
Medical
Center –
pre/post
questionnaire

X

Knowle
dge

Genetic
Genetic Fm
Education
Counseling Mutation Hx

X

X

X

Based on
breast density

X

X
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X

X

No Clinical
Significance
↑ Risk
perception and
↑ screening
adherence
X

X

X

X

Mammo

X

Outcome

X

X

↑adherence
↑knowledge
↓ risk
perception
following
intervention
No Clinical
Significance

X

↑knowledge
with computer
↓anxiety with
one-on-one
counseling

X

↑risk
perception
based on
demographics

Study

Setting

Recommended
Screening

Anxiety/Per
ceived Risk

Haas, et al.

Telephone

Issacs, et
al.

Telephone

Mammo, CBE

X

Katapodi,
et al.

Meta-analysis

Mammo, CBE,
SBE

X

X

Lobb, et
al.

Questionnaire
Pre/post
genetic
counseling

X

Lobb, et
al.

Questionnaire
Pre/post
genetic
counseling

Manley, et
al.

Expert
Opinion

Peshkin, et
al.

Phillips, et
al.

Price, et
al.

X

Knowle
dge

Genetic
Genetic Fm
Education
Counseling Mutation Hx

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Mammo, CBE,
SBE

X

X

X

X

X

Telephone

Mammo, CBE

X

X

X

Questionnaire

Mammo, CBE,
SBE, surgical
risk
management,
chemopreventi
on

Questionnaire

Mammo, CBE,
SBE

X

X
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X

X

X

↓knowledge
↑risk
perception
↑adherence

X

X

Outcome

↑adherence
↑knowledge
↓anxiety
↑knowledge
↓anxiety
Used
standardized
teaching tool
↑knowledge
↓anxiety about
perceived risk
↑knowledge
↓anxiety about
perceived risk
Unable to
determine

X

↑knowledge
↑screening
adherence

X

↑knowledge
↑screening
adherence

Study

Setting

Recommended
Screening

Anxiety/Per
ceived Risk

Price, et
al.

Questionnaire

Rosenthal,
et al.

Data Review

Roussi et
al.

Telephone/
Questionnaire

Sciaraffa,
et al.

Expert
Opinion

Stalmeier,
et al.

Clinic/Home

Tang, et
al.

Telephone

Mammo, CBE

X

Tinley, et
al.

Questionnaire

Mammo, CBE,
SBE

X

X

Knowle
dge

X

Genetic
Genetic Fm
Education
Counseling Mutation Hx

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X
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X

X

X

X

Outcome
↓over
screening
↑knowledge
↓perceived
risk and
anxiety
Recommends
expanded
screening to
rule out all
possible
mutations
↑knowledge
↓anxiety
Described
components to
develop a
RAMP
↑knowledge
↓perceived
risk and
anxiety
Mammograph
y experience
↑adherence
with education
↑knowledge
↓perceived
risk and
anxiety

Appendix D
Breast Cancer Genetics Knowledge Questionnaire - 27
Please choose the correct answer

True False

1.

50% of inherited genetic information (about breast cancer risk) is passed
down form a person's mother.

2.

25% of inherited genetic information (about breast cancer risk) is passed
down from a person's father.

3.

There is more than one gene that can increase the risk of breast cancer.

4.

A woman who has sister with a breast cancer gene mutation has a 1 in 4
chance of having a gene mutation herself.

5.

A father can pass down a breast cancer gene mutation to his own
daughters.

6.

One in 10 women has a breast cancer gene mutation.

7.

All women who have a breast cancer gene mutation will get cancer.
If current available genetic tests were to indicate that a woman has a breast
cancer gene mutation, she is at increased risk for:

8.

Breast Cancer

9.

Ovarian Cancer

10. Lung Cancer
11. Bladder Cancer
If a woman who already had breast cancer was found to have a breast
cancer gene mutation, she is at increased risk for developing:
12. Another breast cancer
13. Ovarian Cancer
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Please choose the correct answer

True False

14. Lung Cancer
15. Bladder Cancer
16.

Women who test positive for breast cancer gene mutations are generally
more likely to develop breast cancer at a young age.

17.

A man who carries a breast cancer gene mutation has an increased risk for
developing breast cancer himself.

18.

If a woman tests positive for breast cancer gene mutation, her male
relative's risk for developing prostate cancer is lowered.

19.

A woman may be at greater risk for developing ovarian cancer if she has
several close relatives with ovarian cancer.

20.

A woman may be at greater risk for developing ovarian cancer if she has
several close relatives with breast cancer.

21.

A woman who has her healthy ovaries removed will definitely not get
ovarian cancer.

22.

A woman who has her breasts removed will definitely not get breast
cancer.

23.

Screening for ovarian cancer often does not detect a tumor until it is more
advanced.

24.

How many copies of a non-working breast cancer gene must one inherit to be at inherited
risk for breast cancer?
a. 0
d. 3
b. 1
e. Do not know
c. 2

25.

What is the approximate risk that the average woman in the United States will develop
breast cancer in her lifetime?
a. 12%
d. 72%
b. 24%
e. Do not know
c. 58%

26.

If a genetic test were to indicate that a woman inherited a breast cancer gene mutation,
then how likely is she to develop breast cancer in her lifetime?
a. up to 15% chance
d. up to 50% chance
b. up to 25% chance
e. up to 85% chance
c. up to 40% chance
f. Do not know
61

27.

Select the procedure that is NOT appropriate for the detection of ovarian cancer.
a. ultrasound
d. pelvic exam
b. pap smear
e. Do not know
c. CA-125 blood test

62

Appendix E
DASS 21
Please read each statement and indicate how much the statement applied to you over the past
week.
There are no right or wrong answers.
Do not spend too much time on any statement.
The rating scale is as follows:
• Did not apply to me at all – NEVER
• Applied to me to some degree, or some of the time – SOMETIMES
• Applied to me to a considerable degree, or a good part of the time – OFTEN
• Applied to me very much, or most of the time – ALMOST ALWAYS

Item

Never

I found it hard to wind down

I was aware of dryness of the mouth

I could not seem to experience any positive
feeling at all
I experienced breathing difficulty (for example,
excessively rapid breathing, breathlessness in
the absence of physical exertion)
I found it difficult to work up the initiative to do
things

I tended to over-react to situations
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Sometimes Often

Almost
always

Item

Never

I experienced trembling (for example, in the
hands)

I felt that I was using a lot of nervous energy

I was worried about situations in which I might
panic and make a fool of myself

I felt that I had nothing to look forward to

I found myself getting agitated

I found it difficult to relax

I felt downhearted and blue

I was tolerant of anything that kept me from
getting on with what I was doing

I felt I was close to panic

I was unable to become enthusiastic about
anything

I felt that I was not worth much as a person
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Sometimes Often

Almost
always

Item

Never

I felt that I was rather touchy
I was aware of the action of my heart in the
absence of physical exertion (for example,
sense of heart rate increase, heart missing a
beat)
I felt scared without any good reason

I felt that life was meaningless
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Sometimes Often

Almost
always

Appendix F
Generalized Self-Efficacy Scale (GES)
Item

Not at
all true

Rarely
true

Moderately
true

Exactly
true

1.

I can always manage to solve difficult
problems if I try hard enough.

1

2

3

4

2.

If someone opposes me, I can find means and
ways to get what I want.

1

2

3

4

3.

It is easy for me to stick to my aims and
accomplish my goals.

1

2

3

4

4.

I am confident that I could deal efficiently
with unexpected events

1

2

3

4

5.

Thanks to my resourcefulness, I know how to
handle unforeseen situations.

1

2

3

4

6.

I can solve most problems if I invest the
necessary effort.

1

2

3

4

7.

I can remain calm when facing difficulties
because I can rely on my coping abilities.

1

2

3

4

8.

When I am confronted with a problem, I can
usually find several solutions.

1

2

3

4

9.

If I am in a bind, I can usually think of
something to do.

1

2

3

4

10.

No matter what comes my way, I'm usually
able to handle it.

1

2

3

4
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Appendix G
Pre-Survey Questionnaire
1. Please enter your age: ______________
2. Please select your education level:
- High School Diploma
- Associate degree
- Bachelor's Degree
- Master's Degree or higher
- Prefer not to answer
3. Please select your marital status:
- Single/never married
- Married or domestic partnership
- Separated
- Divorced
- Widowed
- Prefer not to answer
4. Please select your ethnicity:
- Black/African American
- White/Non-Hispanic
- Hispanic/Latino
- Asian/Pacific Islander
- Native American or American Indian
- Prefer not to answer
5. Have you ever received genetic counseling before?
- Yes
- No
6. When was your last mammogram? ___________
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Appendix H
Post-Survey Questionnaire

1. Do you feel that the education you received has helped with your understanding of your highrisk status?
- Yes
- No
2. Do you feel that the new knowledge you have has helped reduce your anxiety about your
high-risk status?
- Yes
- No
3. Do you feel this will also help you in following the screening recommendations that were
made?
- Yes
- No
4. How many times did you watch the educational video at home? ___________
5. Did anyone in your family view the video?
- Yes
- No
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Appendix I
Determination of Exempt Status Letter
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